Medicare Enrolled

Dr. Madhurima Anne, MD

Hematology & Oncology · Manasquan, NJ
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1707 ATLANTIC AVE, Manasquan, NJ 08736
7325280760
In practice since 2009 (17 years)
NPI: 1326287624 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Anne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anne? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Anne

Dr. Madhurima Anne is a hematology & oncology specialist in Manasquan, NJ, with 17 years of NPI registration. Based on federal Medicare data, Dr. Anne performed 2,607 Medicare services across 1,527 unique beneficiaries.

Between the years covered by Open Payments, Dr. Anne received a total of $2,868 from 54 pharmaceutical and/or device companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Anne is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 42% volume in NJ $2,868 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,607
Medicare services
Top 42% in NJ for hematology & oncology
1,527
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~153 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
834 $103 $434
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
453 $66 $241
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
284 $8 $25
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
281 $8 $10
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
273 $149 $607
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
221 $108 $441
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
89 $67 $309
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
45 $100 $346
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
44 $145 $610
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $134 $564
New patient office visit, complex (60-74 min) 40 $178 $743
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,868
Total received (2018-2024)
Avg $410/year across 7 years
Bottom 48% in NJ for hematology & oncology
54
Companies
168
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,868 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$687
2023
$853
2022
$406
2021
$127
2020
$41
2019
$171
2018
$582

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Genmab U.S., Inc.
$110
TAIHO ONCOLOGY, INC.
$80
Mirati Therapeutics, Inc.
$62
AstraZeneca Pharmaceuticals LP
$50
Janssen Biotech, Inc.
$47
Gilead Sciences, Inc.
$46
Eisai Inc.
$40
Stemline Therapeutics Inc.
$35
GlaxoSmithKline, LLC.
$34
Regeneron Healthcare Solutions, Inc.
$34
ABBVIE INC.
$34
Pharmacosmos Therapeutics Inc.
$20
SpringWorks Therapeutics, Inc.
$19
Apellis Pharmaceuticals, Inc.
$18
Daiichi Sankyo Inc.
$17
PUMA BIOTECHNOLOGY, INC.
$16
PFIZER INC.
$14
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 36.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$337
Stemline Therapeutics Inc.
$182
Gilead Sciences, Inc.
$143
Eisai Inc.
$143
AstraZeneca Pharmaceuticals LP
$124
E.R. Squibb & Sons, L.L.C.
$115
Janssen Biotech, Inc.
$114
Genmab U.S., Inc.
$110
Amgen Inc.
$101
Merck Sharp & Dohme Corporation
$94
Regeneron Healthcare Solutions, Inc.
$81
TAIHO ONCOLOGY, INC.
$80
GlaxoSmithKline, LLC.
$71
Genentech USA, Inc.
$68
PFIZER INC.
$67
Mirati Therapeutics, Inc.
$62
Daiichi Sankyo Inc.
$59
Apellis Pharmaceuticals, Inc.
$54
BeiGene USA, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$44
Exelixis Inc.
$41
Clovis Oncology, Inc.
$40
Celgene Corporation
$39
Acrotech Biopharma Inc.
$36
ABBVIE INC.
$34
Myriad Genetic Laboratories, Inc.
$33
Astellas Pharma US Inc
$31
Merck Sharp & Dohme LLC
$29
Teva Pharmaceuticals USA, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$28
GENZYME CORPORATION
$26
AbbVie Inc.
$26
Seattle Genetics, Inc.
$25
AbbVie, Inc.
$24
G1 Therapeutics, Inc.
$23
Alexion Pharmaceuticals, Inc.
$22
Pharmacosmos Therapeutics Inc.
$20
SpringWorks Therapeutics, Inc.
$19
ADC Therapeutics America, Inc.
$19
Sun Pharmaceutical Industries Inc.
$19
Sirtex Medical Inc
$18
Kite Pharma, Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$16
EISAI INC.
$16
PUMA BIOTECHNOLOGY, INC.
$16
Incyte Corporation
$16
Aadi Bioscience, Inc.
$16
PharmaEssentia USA Corporation
$15
Fresenius Kabi USA, LLC
$15
Seagen Inc.
$14
Emmaus Medical, Inc.
$14
EMD Serono, Inc.
$14
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Foundation Medicine, Inc.
$13
Top 3 companies account for 23.1% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · Abraxane · Alecensa · Avastin · BELEODAQ · BESREMI · BRILINTA · BRUKINSA · Bavencio · Blincyto · CABOMETYX · CALQUENCE · COSELA · Cabometyx · DARZALEX · ELIQUIS · ENHERTU · EPKINLY · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · Erleada · FOUNDATIONONE · Fyarro · GAZYVA · GILOTRIF · GRANIX · Halaven · IMBRUVICA · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · MYLOTARG · MYRISK · NINLARO · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · Orserdu · PADCEV · PIQRAY · PROMACTA · Padcev · PreciseTumor · REBLOZYL · Rubraca · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · Stimufend · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TECVAYLI · VENCLEXTA · Venclexta · XOSPATA · YONSA · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Manasquan?
Compare hematology & oncology specialists in the Manasquan area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
32
Per 100K population
5.0
County median income
$122,727
Nearest hospital
OCEAN MEDICAL CENTER
3.8 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Anne is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Anne experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Anne performed 834 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anne receive payments from pharmaceutical companies?
Yes. Dr. Anne received a total of $2,868 from 54 companies across 168 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anne's costs compare to other hematology & oncology specialists in Manasquan?
Dr. Anne's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →